Company Filing History:
Years Active: 2008-2010
Title: Innovations of Krishnakumar Balasubramanian
Introduction
Krishnakumar Balasubramanian is a notable inventor based in Pearland, Texas. He has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis. With a total of two patents to his name, his work has the potential to impact cancer treatment and tissue regeneration.
Latest Patents
His latest patents focus on the role of Beta-2-glycoprotein 1 as an inhibitor of angiogenesis. The first patent describes a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked β2-Glycoprotein 1 (β2GP1) to cells associated with the tissue. The presence of β2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. Additionally, this patent outlines a method for treating tumors by providing β2GP1 to the tumor. The second patent reiterates these findings, emphasizing the importance of β2GP1 in cancer therapy.
Career Highlights
Krishnakumar Balasubramanian is affiliated with the University of Texas System, where he continues to advance his research. His work has garnered attention for its innovative approach to addressing complex medical challenges.
Collaborations
He has collaborated with esteemed colleagues such as Alan J Schroit and Marya F McCarty, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Krishnakumar Balasubramanian's contributions to the field of biomedical research, particularly through his patents on β2-Glycoprotein 1, highlight his role as an influential inventor. His work not only advances scientific understanding but also holds promise for future medical applications.